Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer

Micro-Abstract Patients with metastatic colorectal cancer are now being exposed to an increasing number of therapeutic agents. The present observational retrospective study reports the clinical practice patterns and characterizes how these agents were used and why they were discontinued in the longi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical colorectal cancer 2016-06, Vol.15 (2), p.135-140
Hauptverfasser: McLean, James, Rho, Young Soo, Kuruba, Gayathri, Mamo, Aline, Gilabert, Marine, Kavan, Tomas, Panasci, Lawrence, Melnychuk, David, Batist, Gerald, Kavan, Petr
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 140
container_issue 2
container_start_page 135
container_title Clinical colorectal cancer
container_volume 15
creator McLean, James
Rho, Young Soo
Kuruba, Gayathri
Mamo, Aline
Gilabert, Marine
Kavan, Tomas
Panasci, Lawrence
Melnychuk, David
Batist, Gerald
Kavan, Petr
description Micro-Abstract Patients with metastatic colorectal cancer are now being exposed to an increasing number of therapeutic agents. The present observational retrospective study reports the clinical practice patterns and characterizes how these agents were used and why they were discontinued in the longitudinal course of patient treatment. FOLFOX (5-fluorouracil, leucovorin, oxaliplatin), FOLFIRI (irinotecan, 5-fluorouracil, leucovorin), and bevacizumab were most frequently used. Most patients discontinued treatment because of disease progression.
doi_str_mv 10.1016/j.clcc.2015.10.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1792775664</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1533002815001188</els_id><sourcerecordid>1792775664</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-f8f9015d965008ad6c2a8efa2bf9ba5d530b1abe42f6eaea516990cb231f77c3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0Eog_4AyxQlmwy-DG2EwkhoQgoUlGrMnvrxrmmHpJ4sB2k_nsczcCii658dH3uke53CHnD6IZRpt7vN3a0dsMpk2WwoVQ8I-esFU1Nld4-L1oKUVPKmzNykdK-KCUYe0nOuJJSSN2ck74b_ewtjNVtBJu9xeoWcsY4p8rPVXePU8j3GOGAS_mtdhEhTzjn6g5_-iJS5UKsvmOGlGF1dGEMEW0ukR3MFuMr8sLBmPD16b0kuy-fd91VfX3z9Vv36bq2W61z7RrXlkuGVklKGxiU5dCgA967tgc5SEF7Bj1uuVMICJKptqW254I5ra24JO-OsYcYfi-Yspl8sjiOMGNYkmG65VpLpbbFyo9WG0NKEZ05RD9BfDCMmhWt2ZsVrVnRrrOCtiy9PeUv_YTD_5V_LIvhw9GA5cg_HqNJ1mMhMPiVhxmCfzr_46N1e6rmFz5g2oclzgWfYSZxQ82Ptdy1W1ZwMdY04i9Gr6B_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1792775664</pqid></control><display><type>article</type><title>Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>McLean, James ; Rho, Young Soo ; Kuruba, Gayathri ; Mamo, Aline ; Gilabert, Marine ; Kavan, Tomas ; Panasci, Lawrence ; Melnychuk, David ; Batist, Gerald ; Kavan, Petr</creator><creatorcontrib>McLean, James ; Rho, Young Soo ; Kuruba, Gayathri ; Mamo, Aline ; Gilabert, Marine ; Kavan, Tomas ; Panasci, Lawrence ; Melnychuk, David ; Batist, Gerald ; Kavan, Petr</creatorcontrib><description>Micro-Abstract Patients with metastatic colorectal cancer are now being exposed to an increasing number of therapeutic agents. The present observational retrospective study reports the clinical practice patterns and characterizes how these agents were used and why they were discontinued in the longitudinal course of patient treatment. FOLFOX (5-fluorouracil, leucovorin, oxaliplatin), FOLFIRI (irinotecan, 5-fluorouracil, leucovorin), and bevacizumab were most frequently used. Most patients discontinued treatment because of disease progression.</description><identifier>ISSN: 1533-0028</identifier><identifier>EISSN: 1938-0674</identifier><identifier>DOI: 10.1016/j.clcc.2015.10.003</identifier><identifier>PMID: 26553578</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenocarcinoma - drug therapy ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Attrition ; Biologic ; Colorectal Neoplasms - drug therapy ; Discontinuation of therapy ; Disease Progression ; Female ; Gastroenterology and Hepatology ; Hematology, Oncology and Palliative Medicine ; Humans ; Longitudinal ; Male ; Middle Aged ; Neoplasm Metastasis ; Practice Patterns, Physicians' - statistics &amp; numerical data ; Real world ; Retrospective Studies ; Salvage Therapy - utilization ; Young Adult</subject><ispartof>Clinical colorectal cancer, 2016-06, Vol.15 (2), p.135-140</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-f8f9015d965008ad6c2a8efa2bf9ba5d530b1abe42f6eaea516990cb231f77c3</citedby><cites>FETCH-LOGICAL-c477t-f8f9015d965008ad6c2a8efa2bf9ba5d530b1abe42f6eaea516990cb231f77c3</cites><orcidid>0000-0003-0296-9950</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.clcc.2015.10.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26553578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McLean, James</creatorcontrib><creatorcontrib>Rho, Young Soo</creatorcontrib><creatorcontrib>Kuruba, Gayathri</creatorcontrib><creatorcontrib>Mamo, Aline</creatorcontrib><creatorcontrib>Gilabert, Marine</creatorcontrib><creatorcontrib>Kavan, Tomas</creatorcontrib><creatorcontrib>Panasci, Lawrence</creatorcontrib><creatorcontrib>Melnychuk, David</creatorcontrib><creatorcontrib>Batist, Gerald</creatorcontrib><creatorcontrib>Kavan, Petr</creatorcontrib><title>Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer</title><title>Clinical colorectal cancer</title><addtitle>Clin Colorectal Cancer</addtitle><description>Micro-Abstract Patients with metastatic colorectal cancer are now being exposed to an increasing number of therapeutic agents. The present observational retrospective study reports the clinical practice patterns and characterizes how these agents were used and why they were discontinued in the longitudinal course of patient treatment. FOLFOX (5-fluorouracil, leucovorin, oxaliplatin), FOLFIRI (irinotecan, 5-fluorouracil, leucovorin), and bevacizumab were most frequently used. Most patients discontinued treatment because of disease progression.</description><subject>Adenocarcinoma - drug therapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Attrition</subject><subject>Biologic</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Discontinuation of therapy</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Gastroenterology and Hepatology</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Longitudinal</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Practice Patterns, Physicians' - statistics &amp; numerical data</subject><subject>Real world</subject><subject>Retrospective Studies</subject><subject>Salvage Therapy - utilization</subject><subject>Young Adult</subject><issn>1533-0028</issn><issn>1938-0674</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhS0Eog_4AyxQlmwy-DG2EwkhoQgoUlGrMnvrxrmmHpJ4sB2k_nsczcCii658dH3uke53CHnD6IZRpt7vN3a0dsMpk2WwoVQ8I-esFU1Nld4-L1oKUVPKmzNykdK-KCUYe0nOuJJSSN2ck74b_ewtjNVtBJu9xeoWcsY4p8rPVXePU8j3GOGAS_mtdhEhTzjn6g5_-iJS5UKsvmOGlGF1dGEMEW0ukR3MFuMr8sLBmPD16b0kuy-fd91VfX3z9Vv36bq2W61z7RrXlkuGVklKGxiU5dCgA967tgc5SEF7Bj1uuVMICJKptqW254I5ra24JO-OsYcYfi-Yspl8sjiOMGNYkmG65VpLpbbFyo9WG0NKEZ05RD9BfDCMmhWt2ZsVrVnRrrOCtiy9PeUv_YTD_5V_LIvhw9GA5cg_HqNJ1mMhMPiVhxmCfzr_46N1e6rmFz5g2oclzgWfYSZxQ82Ptdy1W1ZwMdY04i9Gr6B_</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>McLean, James</creator><creator>Rho, Young Soo</creator><creator>Kuruba, Gayathri</creator><creator>Mamo, Aline</creator><creator>Gilabert, Marine</creator><creator>Kavan, Tomas</creator><creator>Panasci, Lawrence</creator><creator>Melnychuk, David</creator><creator>Batist, Gerald</creator><creator>Kavan, Petr</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0296-9950</orcidid></search><sort><creationdate>20160601</creationdate><title>Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer</title><author>McLean, James ; Rho, Young Soo ; Kuruba, Gayathri ; Mamo, Aline ; Gilabert, Marine ; Kavan, Tomas ; Panasci, Lawrence ; Melnychuk, David ; Batist, Gerald ; Kavan, Petr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-f8f9015d965008ad6c2a8efa2bf9ba5d530b1abe42f6eaea516990cb231f77c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Attrition</topic><topic>Biologic</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Discontinuation of therapy</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Gastroenterology and Hepatology</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Longitudinal</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Practice Patterns, Physicians' - statistics &amp; numerical data</topic><topic>Real world</topic><topic>Retrospective Studies</topic><topic>Salvage Therapy - utilization</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McLean, James</creatorcontrib><creatorcontrib>Rho, Young Soo</creatorcontrib><creatorcontrib>Kuruba, Gayathri</creatorcontrib><creatorcontrib>Mamo, Aline</creatorcontrib><creatorcontrib>Gilabert, Marine</creatorcontrib><creatorcontrib>Kavan, Tomas</creatorcontrib><creatorcontrib>Panasci, Lawrence</creatorcontrib><creatorcontrib>Melnychuk, David</creatorcontrib><creatorcontrib>Batist, Gerald</creatorcontrib><creatorcontrib>Kavan, Petr</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical colorectal cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McLean, James</au><au>Rho, Young Soo</au><au>Kuruba, Gayathri</au><au>Mamo, Aline</au><au>Gilabert, Marine</au><au>Kavan, Tomas</au><au>Panasci, Lawrence</au><au>Melnychuk, David</au><au>Batist, Gerald</au><au>Kavan, Petr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer</atitle><jtitle>Clinical colorectal cancer</jtitle><addtitle>Clin Colorectal Cancer</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>15</volume><issue>2</issue><spage>135</spage><epage>140</epage><pages>135-140</pages><issn>1533-0028</issn><eissn>1938-0674</eissn><abstract>Micro-Abstract Patients with metastatic colorectal cancer are now being exposed to an increasing number of therapeutic agents. The present observational retrospective study reports the clinical practice patterns and characterizes how these agents were used and why they were discontinued in the longitudinal course of patient treatment. FOLFOX (5-fluorouracil, leucovorin, oxaliplatin), FOLFIRI (irinotecan, 5-fluorouracil, leucovorin), and bevacizumab were most frequently used. Most patients discontinued treatment because of disease progression.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26553578</pmid><doi>10.1016/j.clcc.2015.10.003</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0296-9950</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1533-0028
ispartof Clinical colorectal cancer, 2016-06, Vol.15 (2), p.135-140
issn 1533-0028
1938-0674
language eng
recordid cdi_proquest_miscellaneous_1792775664
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adenocarcinoma - drug therapy
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Attrition
Biologic
Colorectal Neoplasms - drug therapy
Discontinuation of therapy
Disease Progression
Female
Gastroenterology and Hepatology
Hematology, Oncology and Palliative Medicine
Humans
Longitudinal
Male
Middle Aged
Neoplasm Metastasis
Practice Patterns, Physicians' - statistics & numerical data
Real world
Retrospective Studies
Salvage Therapy - utilization
Young Adult
title Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T16%3A04%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Practice%20Patterns%20in%20Chemotherapeutic%20Treatment%20Regimens%20for%20Metastatic%20Colorectal%20Cancer&rft.jtitle=Clinical%20colorectal%20cancer&rft.au=McLean,%20James&rft.date=2016-06-01&rft.volume=15&rft.issue=2&rft.spage=135&rft.epage=140&rft.pages=135-140&rft.issn=1533-0028&rft.eissn=1938-0674&rft_id=info:doi/10.1016/j.clcc.2015.10.003&rft_dat=%3Cproquest_cross%3E1792775664%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1792775664&rft_id=info:pmid/26553578&rft_els_id=1_s2_0_S1533002815001188&rfr_iscdi=true